WASHINGTON — Ivermectin, a controversial drug used commonly as a horse dewormer as well as a treatment for parasitic infections in humans, could be capable of treating COVID-19 patients and potentially ending the pandemic, some scientists claim. The team of researchers, including three U.S. government senior scientists, are calling for governments around the world to start treating coronavirus patients with ivermectin. Their findings reveal the drug not only prevents people from contracting COVID, but also defeats the virus and saves lives.
“We did the work that the medical authorities failed to do, we conducted the most comprehensive review of the available data on ivermectin,” says Dr. Pierre Kory, president and chief medical officer of the Front Line COVID-19 Critical Care Alliance (FLCCC), in a media release. “We applied the gold standard to qualify the data reviewed before concluding that ivermectin can end this pandemic.”
Researchers conducted a comprehensive review of 27 reports from clinical, in vitro, animal, and real-world studies. These include 15 randomized controlled trials, which are the preferred scientific method of the World Health Organization, the U.S. National Institutes of Health, and the European Medicines Agency.
Those findings reveal treating COVID-19 patients with ivermectin resulted in large drops in coronavirus deaths. The recovery time from an infection and the time it takes to clear COVID from someone’s system also saw significant reductions among patients on ivermectin.
Additionally, three randomized controlled trials and five observational controlled trials which included nearly 2,500 healthy participants discovered using ivermectin noticeably reduces the risk of contracting COVID-19.
Many countries are already using ivermectin, but why not everywhere?
Study authors note that several regions globally now recognize this drug as both a powerful vaccine and treatment for COVID-19. The countries of South Africa, Zimbabwe, Slovakia, the Czech Republic, Mexico, and India have all approved ivermectin’s use during the pandemic, according to the team. Researchers add their findings show that immediate global distribution of ivermectin will likely lead to “rapid population-wide decreases in morbidity and mortality.”
So the question is, why aren’t doctors in the United States and elsewhere using ivermectin to treat COVID patients in 2021? Study authors don’t have an answer for that, but are urging doctors everywhere to demand that local and national health officials add ivermectin to the list of approved coronavirus treatments right away.
“Our latest research shows, once again, that when the totality of the evidence is examined, there is no doubt that ivermectin is highly effective as a safe prophylaxis and treatment for COVID-19,” adds Dr. Paul E. Marik, founding member of the FLCCC and chief of Pulmonary and Critical Care Medicine at Eastern Virginia Medical School.
“We can no longer rely on many of the larger health authorities to make an honest examination of the medical and scientific evidence. So, we are calling on regional public health authorities and medical professionals around the world to demand that ivermectin be included in their standard of care right away so we can end this pandemic once and for all.”
The findings appear in the American Journal of Therapeutics.
Editor’s note: As explicitly written in our Mission & Standards statement, StudyFinds does “not agree nor disagree with any of the studies we post, rather, we encourage our readers to debate the veracity of the findings themselves.”